| Introduction
Current state policies vary
considerably, including the extent to which they permit opioid therapy for patients with
chronic pain. The rapid increase in state pain-related policy should be monitored
closely and pain professionals and their organizations should actively influence the
development of state pain policies. Various state policies are discussed below.
Alabama
Arkansas
Florida
Georgia
In 1991, the Georgia Composite State Board
of Medical Examiners stated that the diagnosis of pain should be based on the patient's
history and a physical examination, not simply on the assertion of the patient. The
treatment plan should reflect the use of other modalities of treatment, including
appropriate referrals and their results, and document the reasons that past modalities
have been inappropriate or ineffective. The physician should determine that the
patient is not taking opioids for nontherapeutic purposes and should obtain the informed
consent of the patient before using opioids. Furthermore, the patient should be
monitored regularly, and the physician should have adequate control of the drug supply,
including detailed records of each drug dose, amount, and number of refills. The
physician should maintain regular contact with the patient's family to assess treatment
effectiveness. Adequate records should be maintained.
Louisiana
Mississippi
Unlike other states which have specifically passed legislation or policy
statements to help address physician's concerns about regulatory scrutiny and discuss the
proper use of controlled substances in the treatment of pain, the state of Mississippi
continues to remain in the minority by remaining silent on the issue.
South Carolina
In February 1999, South Carolina became the
first state to adopt the Federation of State Medical Board's Guidelines for the Use of
Controlled Substances in the Treatment of Pain. The model guidelines: state
that effective pain management is part of good medical practice; address physician's
concerns about regulatory scrutiny by clarifying the board's policy; explain how the board
distinguishes legitimate medical practice from unprofessional conduct; and encourage
physician education by providing references to clinical practice guidelines that are
available. The SBMMSC guidelines provide a reasonable set of recommended parameters
based on principles of good medical practice for physicians' use of controlled substances
for pain management.
|